SUPERINFECTION OF HTLV-III/LAV-INFECTED HUMAN LYMPHOCYTES-T WITH CMV RESULTS IN A HIGH-RATE OF CELL-LYSIS

被引:0
|
作者
CASAREALE, D
FIALA, M
CONE, LA
CHANG, CM
机构
[1] EISENHOWER MED CTR,RANCHO MIRAGE,CA
[2] SCRIPPS CLIN & RES FDN,LA JOLLA,CA 92037
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:50 / 50
页数:1
相关论文
共 25 条
  • [11] ISOLATION AND CHARACTERIZATION OF A T-CELL CLONE PRODUCING DEFECTIVE HUMAN T-LYMPHOTROPIC VIRUS-III LYMPHADENOPATHY ASSOCIATED VIRUS (HTLV-III/LAV) PARTICLES
    POWELL, DM
    FOLKS, T
    LIGHTFOOTE, MM
    RABSON, A
    KOENIG, S
    FAUCI, AS
    MARTIN, M
    [J]. FEDERATION PROCEEDINGS, 1986, 45 (03) : 252 - 252
  • [12] INDUCTION OF HUMAN T-LYMPHOTROPIC VIRUS-III LYMPHADENOPATHY ASSOCIATED VIRUS (HTLV-III/LAV) FROM A NONVIRUS-PRODUCING T-CELL LINE
    FOLKS, T
    POWELL, DM
    BENN, S
    MARTIN, M
    FAUCI, AS
    [J]. FEDERATION PROCEEDINGS, 1986, 45 (03) : 253 - 253
  • [13] AURINTRICARBOXYLIC ACID (ATA) INHIBITS THE CYTOPATHOGENICITY OF HUMAN T-CELL LYMPHOTROPIC VIRUS (HTLV-III)/LYMPHADENOPATHY-ASSOCIATED VIRUS (LAV)
    BALZARINI, J
    MITSUYA, H
    DECLERCQ, E
    BRODER, S
    [J]. ARCHIVES INTERNATIONALES DE PHYSIOLOGIE DE BIOCHIMIE ET DE BIOPHYSIQUE, 1986, 94 (01): : B4 - B5
  • [14] THE LOCATION OF CIS-ACTING REGULATORY SEQUENCES IN THE HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-III (HTLV-III/LAV) LONG TERMINAL REPEAT
    ROSEN, CA
    SODROSKI, JG
    HASELTINE, WA
    [J]. CELL, 1985, 41 (03) : 813 - 823
  • [15] DIFFERENTIAL RESPONSE TO THE CYTOPATHIC EFFECTS OF HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-III (HTLV-III) SUPERINFECTION IN T4+ (HELPER) AND T8+ (SUPPRESSOR) T-CELL CLONES TRANSFORMED BY HTLV-I
    DEROSSI, A
    FRANCHINI, G
    ALDOVINI, A
    DELMISTRO, A
    CHIECOBIANCHI, L
    GALLO, RC
    WONGSTAAL, F
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (12) : 4297 - 4301
  • [16] EFFECTS OF MUTATIONS WITHIN THE 3' ORF OPEN READING FRAME REGION OF HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-III (HTLV-III/LAV) ON REPLICATION AND CYTOPATHOGENICITY
    TERWILLIGER, E
    SODROSKI, JG
    ROSEN, CA
    HASELTINE, WA
    [J]. JOURNAL OF VIROLOGY, 1986, 60 (02) : 754 - 760
  • [17] NATURAL-KILLER ACTIVITY FROM NORMAL PERIPHERAL-BLOOD LYMPHOCYTES AGAINST A HUMAN T-LYMPHOTROPIC RETROVIRUS TYPE-III (HTLV-III)-INFECTED CELL-LINE
    SIRIANNI, MC
    DESANCTIS, G
    MACCHI, B
    SODDU, S
    ENSOLI, F
    AIUTI, F
    FONTANA, L
    [J]. DIAGNOSTIC AND CLINICAL IMMUNOLOGY, 1988, 5 (06): : 297 - 303
  • [18] FACTORS AFFECTING SEROPOSITIVITY TO HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-III (HTLV-III) OR LYMPHADENOPATHY ASSOCIATED VIRUS (LAV) AND PROGRESSION OF DISEASE IN SEXUAL PARTNERS OF PATIENTS WITH AIDS
    WEBER, JN
    MCCREANER, A
    BERRIE, E
    WADSWORTH, J
    JEFFRIES, DJ
    PINCHING, AJ
    HARRIS, JRW
    [J]. GENITOURINARY MEDICINE, 1986, 62 (03): : 177 - 180
  • [19] LYSIS OF HUMAN T-CELL LEUKEMIA-VIRUS (HTLV-I) INFECTED HUMAN-LYMPHOCYTES BY LYMPHOKINE ACTIVATED KILLER (LAK) CELLS
    FROELICH, CJ
    LONGO, D
    GUIFFAUT, S
    [J]. CLINICAL RESEARCH, 1985, 33 (04): : A918 - A918
  • [20] COMPARATIVE INHIBITORY EFFECTS OF SURAMIN AND OTHER SELECTED COMPOUNDS ON THE INFECTIVITY AND REPLICATION OF HUMAN T-CELL LYMPHOTROPIC VIRUS (HTLV-III) LYMPHADENOPATHY-ASSOCIATED VIRUS (LAV)
    BALZARINI, J
    MITSUYA, H
    DECLERCQ, E
    BRODER, S
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1986, 37 (03) : 451 - 457